AEON Biopharma, Inc. (AEON)

CIK 1837607 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for AEON Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 202630000935836-26-000438
Aug 21, 2026SCHEDULE 13G0000935836-26-000442
Aug 21, 202640000935836-26-000440
Aug 12, 202610-Q0001837607-26-000062
Aug 12, 20268-K0001837607-26-000061
Aug 3, 20268-K0001837607-26-000057
Jul 23, 20268-K0001837607-26-000055
Jul 21, 2026SCHEDULE 13G0001440771-26-000012
Jul 15, 2026424B40001104659-26-083680
Jul 15, 20268-K0001837607-26-000052
Jul 13, 2026S-1MEF0001104659-26-083252
Jul 13, 2026EFFECT9999999995-26-002285
Jul 9, 2026S-1/A0001104659-26-082167
Jul 8, 2026S-10001104659-26-081860
Jun 22, 202640001104659-26-076513
Jun 22, 202640001104659-26-076515
Jun 22, 202640001104659-26-076511
Jun 22, 202640001104659-26-076509
Jun 22, 202640001104659-26-076510
Jun 17, 20268-K0001837607-26-000046
May 14, 202610-Q0001837607-26-000042
May 14, 20268-K0001837607-26-000041
May 14, 20268-K0001837607-26-000043
Apr 29, 2026ARS0001837607-26-000035
Apr 29, 2026DEFA14A0001837607-26-000034